You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myeloablative consolidation chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)

Recruiting
  • Neuroblastoma
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 2, 2022

ASCT Versus Chemotherapy as First-Line Consolidation Therapy

Completed
  • T-cell Lymphoma Adults
  • consolidation with ASCT
  • (no location specified)
Nov 25, 2023

Esophageal Squamous Cell Carcinoma, Chemo Effect, Side Effect of Drug Trial in Nanjing (Consolidation chemo (4 courses),

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Consolidation chemotherapy (4 courses)
  • Concurrent chemotherapy (2 courses)
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Mar 16, 2023

Rectal Tumors Trial in Larissa (Neoadjuvant Chemoradiotherapy, Adjuvant Chemotherapy, Consolidation Chemotherapy)

Not yet recruiting
  • Rectal Neoplasms
  • Neoadjuvant Chemoradiotherapy
  • +2 more
  • Larissa, Greece
    Department of Surgery, University Hospital of Larissa
Aug 10, 2022

NSCLC Trial (Durvalumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Jun 22, 2023

NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

Recruiting
  • Non-small Cell Lung Cancer
  • Hypofractionated radiotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Nov 14, 2023

Acute Myeloid Leukemia, MDS Trial in Ulm (drug, combination product, other)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Berlin, Germany
  • +9 more
Jan 13, 2023

Rectal Cancer Trial in Santiago (drug, radiation, behavioral, procedure)

Recruiting
  • Rectal Cancer
  • Santiago, RM, Chile
  • +2 more
Oct 24, 2022

Gallbladder Cancer Unresectable Trial in Lucknow (chemoradiation)

Recruiting
  • Gallbladder Cancer Unresectable
  • chemoradiation
  • Lucknow, Uttar Pradesh, India
    Sanjay Gandhi Postgraduate Institute of Medical Sciences
Aug 6, 2022

Cancer Patients Receiving Stereotactic Body RTX Trial in Dallas (SBRT)

Recruiting
  • Cancer Patients Receiving Stereotactic Body RTX
  • SBRT
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Aug 25, 2022

Limited Stage Small Cell Lung Cancer Trial (HLX10, hypofractionated radiotherapy, Prophylactic Cranial Irradiation (PCI))

Not yet recruiting
  • Limited Stage Small Cell Lung Cancer
  • (no location specified)
Jun 29, 2022

Lung Cancer, Extensive-stage Small-cell Lung Cancer, Radiotherapy Trial (Durvalumab + carboplatin/cisplatin + etoposide,

Not yet recruiting
  • Lung Cancer
  • +2 more
  • Durvalumab + carboplatin/cisplatin + etoposide
  • +2 more
  • (no location specified)
Aug 3, 2022

NSCLC Trial in Philadelphia (Pembrolizumab)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 1, 2022

FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia Trial (midostaurin)

Available
  • FMS-Like Tyrosine Kinase 3-mutated Acute Myeloid Leukemia
  • (no location specified)
Oct 18, 2022

NSCLC Trial in Ostrava (primary tumour radiotherapy, stereotactic body radiotherapy, maintenance radiotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • primary tumour radiotherapy
  • +2 more
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Dec 6, 2022

Rectal Cancer Trial in Mecca (Chemotherapy)

Recruiting
  • Rectal Cancer
  • Mecca, Makkah Western, Saudi Arabia
    King Abdullah Medical City, Holy Capital
Apr 5, 2022

Locally Advanced NSCLC, Efficacy and Safety Trial in Guangzhou (Anlotinib, Chemotherapy, Radiotherapy)

Recruiting
  • Locally Advanced Non-small Cell Lung Cancer
  • Efficacy and Safety
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 28, 2022

Allo-HSCT as First-line Consolidation in High-risk PTCL

Recruiting
  • T Cell Lymphoma
    • Beijing, China
      Peking University People's Hospital
    Jul 31, 2022

    Locally Advanced Rectal Cancer Trial in Pisa (drug, radiation, procedure)

    Recruiting
    • Locally Advanced Rectal Cancer
    • Pisa, Italy
      U.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Univ
    Mar 9, 2022

    Esophageal Tumor Metastatic, Esophageal Cancer Stage IVb Trial in Beijing (drug, biological, radiation)

    Recruiting
    • Esophageal Neoplasm Metastatic
    • Esophageal Cancer Stage IVb
    • TP (Paclitaxel with cisplatin or carboplatin) or PF (Fluoropyrimidine with cisplatin or carboplatin) regimen depended on investigator's choice.
    • +3 more
    • Beijing, Beijing, China
      Cancer hospital, CAMS
    Oct 19, 2023

    Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an

    Recruiting
    • Precursor Cell Lymphoblastic Leukemia-Lymphoma
    • +2 more
    • dasatinib plus consolidation chemotherapy with vincristine and prednisone
    • dasatinib plus consolidation chemotherapy with high-dose methotrexate and cytarabine
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xian Jiaotong University
    Sep 29, 2021

    Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)

    Active, not recruiting
    • Metastatic Melanoma
    • Skin Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Stage III Non-small-cell Lung Cancer Trial in Foshan, Guangzhou (other, radiation, drug)

    Recruiting
    • Stage III Non-small-cell Lung Cancer
    • Neoadjuvant therapy
    • +4 more
    • Foshan, Guangdong, China
    • +2 more
    Oct 25, 2022

    Stage III NSCLC Trial in Guangzhou (Neoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy)

    Recruiting
    • Stage III Non-small Cell Lung Cancer
    • Neoadjuvant chemo-immunotherapy
    • +5 more
    • Guangzhou, China
      Sun Yat-sen University
    Jul 19, 2022

    Rectal Cancer Trial in New York (Etrumadenant (AB928), Radiation therapy, FOLFOX regimen)

    Recruiting
    • Rectal Cancer
    • Etrumadenant (AB928)
    • +3 more
    • New York, New York
    • +2 more
    Apr 10, 2022